114 related articles for article (PubMed ID: 38492821)
1. Mutational profile evaluates metastatic capacity of Chinese colorectal cancer patients, revealed by whole-exome sequencing.
Yang Y; Chen J; Peng H; Xiao Z; Xu W; Zheng M; Li Z; Cao P
Genomics; 2024 May; 116(3):110809. PubMed ID: 38492821
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of colorectal cancer using whole-exome sequencing in a Taiwanese population.
Chang YS; Lee CC; Ke TW; Chang CM; Chao DS; Huang HY; Chang JG
Cancer Med; 2019 Jul; 8(8):3738-3747. PubMed ID: 31127692
[TBL] [Abstract][Full Text] [Related]
3. Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
Yan P; Wang Y; Meng X; Yang H; Liu Z; Qian J; Zhou W; Li J
Inflamm Bowel Dis; 2019 Jul; 25(8):1293-1301. PubMed ID: 30794281
[TBL] [Abstract][Full Text] [Related]
4. New genetic variations discovered in KRAS wild-type cetuximab resistant chinese colorectal cancer patients.
Jing C; Wang T; Ma R; Cao H; Wang Z; Liu S; Chen D; Zhang J; Wu Y; Zhang Y; Wu J; Feng J
Mol Carcinog; 2020 May; 59(5):478-491. PubMed ID: 32141150
[TBL] [Abstract][Full Text] [Related]
5. Single-cell exome sequencing reveals multiple subclones in metastatic colorectal carcinoma.
Tang J; Tu K; Lu K; Zhang J; Luo K; Jin H; Wang L; Yang L; Xiao W; Zhang Q; Liu X; Ge XY; Li G; Zhou Z; Xie D
Genome Med; 2021 Sep; 13(1):148. PubMed ID: 34507604
[TBL] [Abstract][Full Text] [Related]
6. Exome sequencing reveals the genetic landscape and frequent inactivation of PCDHB3 in Chinese rectal cancers.
Ye W; Ling S; Liu RY; Pan ZZ; Wang G; Gao S; Wu J; Cao L; Dong L; Li Y; Zhou Y; Du W; Meng X; Chen J; Guan X; He Y; Pan C; Zheng XS; Lu X; Chen S; Huang W
J Pathol; 2018 Jun; 245(2):222-234. PubMed ID: 29537081
[TBL] [Abstract][Full Text] [Related]
7. High Concordance of Genomic Profiles between Primary and Metastatic Colorectal Cancer.
Lee SE; Park HY; Hwang DY; Han HS
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34074070
[TBL] [Abstract][Full Text] [Related]
8. Clinical and genetic determinants of ovarian metastases from colorectal cancer.
Ganesh K; Shah RH; Vakiani E; Nash GM; Skottowe HP; Yaeger R; Cercek A; Lincoln A; Tran C; Segal NH; Reidy DL; Varghese A; Epstein AS; Sonoda Y; Chi D; Guillem J; Temple L; Paty P; Hechtman J; Shia J; Weiser M; Aguilar JG; Kemeny N; Berger MF; Saltz L; Stadler ZK
Cancer; 2017 Apr; 123(7):1134-1143. PubMed ID: 27875625
[TBL] [Abstract][Full Text] [Related]
9. Candidate colorectal cancer predisposing gene variants in Chinese early-onset and familial cases.
Zhang JX; Fu L; de Voer RM; Hahn MM; Jin P; Lv CX; Verwiel ET; Ligtenberg MJ; Hoogerbrugge N; Kuiper RP; Sheng JQ; Geurts van Kessel A
World J Gastroenterol; 2015 Apr; 21(14):4136-49. PubMed ID: 25892863
[TBL] [Abstract][Full Text] [Related]
10. A pathway-centric survey of somatic mutations in Chinese patients with colorectal carcinomas.
Ling C; Wang L; Wang Z; Xu L; Sun L; Yang H; Li WD; Wang K
PLoS One; 2015; 10(1):e0116753. PubMed ID: 25617745
[TBL] [Abstract][Full Text] [Related]
11. Lack of APC somatic mutation is associated with early-onset colorectal cancer in African Americans.
Xicola RM; Manojlovic Z; Augustus GJ; Kupfer SS; Emmadi R; Alagiozian-Angelova V; Triche T; Salhia B; Carpten J; Llor X; Ellis NA
Carcinogenesis; 2018 Dec; 39(11):1331-1341. PubMed ID: 30239619
[TBL] [Abstract][Full Text] [Related]
12. Next-generation sequencing analysis suggests varied multistep mutational pathogenesis for endocrine mucin-producing sweat gland carcinoma with comments on INSM1 and MUC2 suggesting a conjunctival origin.
Mathew JG; Bowman AS; Saab J; Busam KJ; Nehal K; Pulitzer M
J Am Acad Dermatol; 2022 May; 86(5):1072-1079. PubMed ID: 33515627
[TBL] [Abstract][Full Text] [Related]
13. SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients.
Mei Z; Shao YW; Lin P; Cai X; Wang B; Ding Y; Ma X; Wu X; Xia Y; Zhu D; Shu Y; Fu Z; Gu Y
BMC Cancer; 2018 Apr; 18(1):479. PubMed ID: 29703253
[TBL] [Abstract][Full Text] [Related]
14. Somatic mutation profiling and HER2 status in KRAS-positive Chinese colorectal cancer patients.
Dong Z; Kong L; Wan Z; Zhu F; Zhong M; Lv Y; Zhao P; Shi H
Sci Rep; 2019 Nov; 9(1):16894. PubMed ID: 31729406
[TBL] [Abstract][Full Text] [Related]
15. Comparative genomic signatures in young and old Chinese patients with colorectal cancer.
Wang F; Cheng H; Zhang X; Shan L; Bai B; Chen K; Lou F; Cao S; Wang H; Dai S
Cancer Med; 2021 Jul; 10(13):4375-4386. PubMed ID: 34041865
[TBL] [Abstract][Full Text] [Related]
16. Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine.
Nagahashi M; Wakai T; Shimada Y; Ichikawa H; Kameyama H; Kobayashi T; Sakata J; Yagi R; Sato N; Kitagawa Y; Uetake H; Yoshida K; Oki E; Kudo SE; Izutsu H; Kodama K; Nakada M; Tse J; Russell M; Heyer J; Powers W; Sun R; Ring JE; Takabe K; Protopopov A; Ling Y; Okuda S; Lyle S
Genome Med; 2016 Dec; 8(1):136. PubMed ID: 28007036
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel mutations by exome sequencing in African American colorectal cancer patients.
Ashktorab H; Daremipouran M; Devaney J; Varma S; Rahi H; Lee E; Shokrani B; Schwartz R; Nickerson ML; Brim H
Cancer; 2015 Jan; 121(1):34-42. PubMed ID: 25250560
[TBL] [Abstract][Full Text] [Related]
18. Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer.
Yu J; Wu WK; Li X; He J; Li XX; Ng SS; Yu C; Gao Z; Yang J; Li M; Wang Q; Liang Q; Pan Y; Tong JH; To KF; Wong N; Zhang N; Chen J; Lu Y; Lai PB; Chan FK; Li Y; Kung HF; Yang H; Wang J; Sung JJ
Gut; 2015 Apr; 64(4):636-45. PubMed ID: 24951259
[TBL] [Abstract][Full Text] [Related]
19. Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis.
Wei Q; Ye Z; Zhong X; Li L; Wang C; Myers RE; Palazzo JP; Fortuna D; Yan A; Waldman SA; Chen X; Posey JA; Basu-Mallick A; Jiang BH; Hou L; Shu J; Sun Y; Xing J; Li B; Yang H
Ann Oncol; 2017 Sep; 28(9):2135-2141. PubMed ID: 28911083
[TBL] [Abstract][Full Text] [Related]
20. Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.
Mogensen MB; Rossing M; Østrup O; Larsen PN; Heiberg Engel PJ; Jørgensen LN; Hogdall EV; Eriksen J; Ibsen P; Jess P; Grauslund M; Nielsen HJ; Nielsen FC; Vainer B; Osterlind K
BMC Cancer; 2018 Jul; 18(1):752. PubMed ID: 30029640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
